医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Ancillare’s Peter Knapp to Kick off “Innovating the Supply Chain” at the World’s Premier End-to-End Supply Chain Management Conference

2016年09月01日 AM05:09
このエントリーをはてなブックマークに追加


 

HORSHAM, Pa.

Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain management services for pharmaceutical, biotechnology, contract research and medical research organizations, will share expertise and best practices to the LogiPharma US 2016 conference in Princeton, New Jersey. Peter Knapp, Vice President of Logistics and Global Expansion, Ancillare, LP will chair the event and speak on relevant topics during the “Innovating the Supply Chain” track on September 21, 2016 beginning at 8:45AM.

With the growing complexities of global supply chains, increased regulations, new technologies, out of control costs, request for more transparency, the call for innovative solutions in the chain is a must. Peter Knapp will join other key thought leaders to address innovative solutions for transforming the supply chain, such as:

  • Juan Fernando Forero, Sr. Director Supply Chain Leader Global Innovation Pharma (GIP), Pfizer
  • Ronald Keegan, Associate Director Supply Chain at Ohm Labs, Sunpharma
  • Ed Ram, Director, Supplier Relations, Global Sourcing Department, Sagent
  • Paul Clayton, Former VP Supply Chain, Logistics and IT, Formerly GlaxoSmithKline
  • Plus Many More

LogiPharma is the largest global end-to-end supply chain forum for pharmaceutical supply chain leaders, their teams and service partners for exchanging knowledge and innovating ideas.

“Innovation is to amend our future,” said Peter Knapp. “Innovative supply chain management is the key enabler for globalization, lean management and cost control.”

“We are very excited for Peter to share important insights on innovating the supply chain in the 21st Century,” said Joanne Santomauro, Chief Executive Officer and Founder at Ancillare, LP. “The ancillary supply chain management industry in 2006 was created by Ancillare, LP. Prior to the company launch, pharmaceutical, biotechnology and medical research organizations had little transparency to the overall supply chain and had a limited grasp of the associated costs, processes, and regulatory and compliance requirements of this diverse global supply chain.”

About Ancillare, LP

Ancillare, LP has extensive experience delivering cost savings and efficiencies to supply chains, with a complete turn-key approach for managing the pharmaceutical, biotechnology, contract research and medical research organizations’ clinical trial supply chains with a singular focus. Our turn-key global model (A-TKOTM) centralizes supply operations which accelerates the processes, lowers costs and mitigates risk by making clinical supply chains more efficient, cost-effective and global.

Our capabilities include pre-protocol analysis and planning, contribution to overall program feasibility assessments and timeline development, product sourcing and procurement, forecasting and budgeting, large and small equipment and consumables management, patient retention and recruitment materials, customs clearance, import/export (including IOR/EOR), storage, kitting, distribution and returns management/disposition (including destruction, refurbishment/recalibration and redeployment) on a global level.

Ancillare has managed the supply chain for top pharmaceutical and CRO organizations and has successfully transported goods to 100 countries. Ancillare has master depots in United States, United Kingdom and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan and Ukraine. To learn more, visit www.ancillare.com or contact us via LinkedIn, Twitter and Facebook.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160831006432/en/

CONTACT

Ancillare, LP
Courtney Ingram, 215-699-1700 ext. 107
Courtney.Ingram@Ancillare.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa® (gefitinib) in First-Line Non-Small Cell Lung Cancer
  • 2020年迪拜世界博览会启动 Expo Live:一个造福社会的创新与合作项目
  • Washington University in St. Louis to Host Major Forum on Aging; Gathering in Shanghai Brings Together Greater China University Research Partners to Address Unprecedented Global Social Challenge
  • 圣路易斯华盛顿大学将举办老龄化问题大型论坛;在上海举行的论坛将聚集大中华区大学研究合作伙伴,讨论应对前所未有的全球性社会挑战
  • Tocagen Expands Toca 5, Phase 2/3 Clinical Trial for Recurrent Brain Cancer, to South Korea